Study of mechanism of action of antipsychotic drugs in the animal model of schizophrenia

抗精神病药物在精神分裂症动物模型中的作用机制研究

基本信息

  • 批准号:
    09670969
  • 负责人:
  • 金额:
    $ 1.92万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1999
  • 项目状态:
    已结题

项目摘要

The effect of non-competitive NMDA receptor antagonist phencyclidine (PCP) on the binding to dopamine DィイD22ィエD2 and serotonin 5-HTィイD22AィエD2 receptor was examined in the rat striatum and frontal cortex, respectively. Neither acute or 3-week treatment with 5 mg/kg PCP had any significant effect on DィイD22ィエD2 and 5-HTィイD22AィエD2 receptors. Acute or 8-day footshock stress (1 series: 2.5 mA for 30 sec, randam interval; mean 30 sec, 30 times) did not significantly affect the D2 and 5-HTィイD22AィエD2 receptors in both saline- and PCP (5 mg/kg)-treated rats. However, stress-induced changes in the DィイD22ィエD2 and 5-HTィイD22AィエD2receptors were different, although not significantly, between the two groups. It is possible that PCP treatment may influence the dopaminergic and serotonergic compensatory systems to stress.The effects of 3-week treatment with a atypical antipsychotic drug chlorpromazine and three typical antipsychotic drugs (risperidone, olanzapine and perospirone) on the binding to DィイD22 … More ィエD2 and 5-HTィイD22AィエD2 receptors were examined in the rat striatum and frontal cortex, respectively. Subchronic treatment with chlorpromazine (10 mg/kg) and perospirone (1 mg/kg) significantly increased DィイD22ィエD2 receptors, while no increase was observed with lower dose of chlorpromazine (5 mg/kg), perospirone (0.1 mg/kg), risperidone (0.25, 0.5 mg/kg) or olanzapine (1, 2 mg/kg). On the other hand, 3-week administration of chlorpromazine (5, 10 mg/kg)and olanzapine (1, 2 mg/kg) significantly decreased 5-HTィイD22AィエD2 receptors, but risperidone (0.25, 0.5 mg/kg) or perospirone (0.1, 1 mg/kg) had no effect. The measurement of in vivo drug occupation for DィイD22ィエD2 and 5-HTィイD22AィエD2 receptors using N-ethoxycarbony1-2-ethoxy-1, 2-dihydroquinoline (EEDQ) suggested that high occupation of 5-HTィイD22AィエD2 receptors with lower DィイD22ィエD2 receptor occupancy might be involved in the absence of up-regulation of DィイD22ィエD2 receptors after subchronic treatment with some atypical antipsychotic drugs. Less
本实验观察了非竞争性N-甲基-D-天冬氨酸受体拮抗剂苯环利定对大鼠纹状体和额叶皮质多巴胺D-羟色胺D22-羟色胺D22-ィイ-D2和5-羟色胺-5-羟色胺-ィエ-D22A-ィイ-D2受体结合的影响。5 mg/kgPCP急性给药或3周给药对D-ィイ、D22、ィエ、D2和5-HT、ィイ、D22A、ィエ、D2受体均无明显影响。急性或8天足电击应激(1系列:2.5 mA,随机间隔30秒;平均30秒,30次)对生理盐水和五氯苯酚(5 mg/kg)处理的大鼠的D2和5-羟色胺ィイD22AィエD2受体没有显著影响。然而,应激诱导的D-ィイD22ィエD2和5-HTィイD22AィエD2受体的变化在两组之间是不同的,尽管没有显著差异。氯丙嗪与3种典型抗精神病药物(利培酮、奥氮平和培螺酮)联合治疗3周对D-ィイD22…结合的影响ィエD2和5-羟色胺ィイD22AィエD2受体分别在大鼠纹状体和额叶皮质表达。亚慢性给予氯丙嗪(10 mg/kg)和洛氮平(1 mg/kg)后,DィイD22ィエD2受体显著增加,而低剂量氯丙嗪(5 mg/kg)、丙螺酮(0.1 mg/kg)、利培酮(0.2 5 mg/kg)或奥氮平(1、2 mg/kg)则无明显增加。给予氯丙嗪(5,10 mg/kg)和奥氮平(1,2 mg/kg)3周后,5-羟色胺ィイD22AィエD2受体明显减少,而利培酮(0.25,0.5 mg/kg)或培螺酮(0.1,1 mg/kg)无明显作用。用N-乙氧基碳基-2-乙氧基-1,2-二氢喹啉测定D-ィイD22ィエD2和5-HTィイD22AィエD2受体在体内的药物占有率表明,5-HTィイD22AィエD2受体占有率高而DィイD22ィエD2受体占有率较低可能与一些非典型抗精神病药物亚慢性治疗后DィイD22ィエD2受体没有上调有关。较少

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kusumi I.: "Algorithms for the treatment of acute side effects induced by neuroleptics"Psychiat.Clin.Neurosci.. 53(suppl.). s19-s22 (1999)
Kusumi I.:“治疗精神安定药引起的急性副作用的算法”Psychiat.Clin.Neurosci.. 53(增刊)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
久住 一郎: "病態・病理-精神化学/臨床精神医学講座2精神分裂病I" 中山書店, 149-167 (1999)
久住一郎:“医疗状况/病理学 - 心理化学/临床精神病学课程 2 精神分裂症 I” 中山书店,149-167 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
久住一郎: "精神分裂病のアルゴリズム―急性の副作用"星和書店(精神分裂病と気分障害の治療手順). 179 (1998)
Ichiro Kusumi:“精神分裂症算法 - 急性副作用”Seiwa Shoten(精神分裂症和情绪障碍的治疗程序)179(1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sato, M.: "Algorithm for the treatment of schizophrenia in Japan"Int. J. Psychiat. Clin. Pract.. 3. 271-276 (1999)
Sato, M.:“日本治疗精神分裂症的算法”Int。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takahashi Y: "In vivo occupation of dopamine D_1,D_2 and serctonin (5HT) _<2A> receptors by sertindole in the rat brain." J.Psychiat.& Neurosci.23. 157-162 (1998)
Takahashi Y:“舍吲哚在大鼠大脑中体内占领多巴胺 D_1、D_2 和血清素 (5HT) _<2A> 受体。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUSUMI Ichiro其他文献

KUSUMI Ichiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUSUMI Ichiro', 18)}}的其他基金

Systematic evaluation of endophenotypes for patients with at risk mental state and first-episode schizophrenia
精神状态高危患者和首发精神分裂症患者内表型的系统评估
  • 批准号:
    23591687
  • 财政年份:
    2011
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Neurophysiological study on cognitive pathology of depression : relevant to anterior cingulate cortex
抑郁症认知病理学的神经生理学研究:与前扣带皮层相关
  • 批准号:
    20591385
  • 财政年份:
    2008
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of endoplasmic reticulum stress response in the pathophysiology of bipolar disorder
内质网应激反应在双相情感障碍病理生理学中的作用
  • 批准号:
    17591192
  • 财政年份:
    2005
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular biological study on the pathophysiology of bipolar disorders
双相情感障碍病理生理学的分子生物学研究
  • 批准号:
    15591206
  • 财政年份:
    2003
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular biological study of mechanism of action of atypical antipsychotic drugs
非典型抗精神病药物作用机制的分子生物学研究
  • 批准号:
    13670978
  • 财政年份:
    2001
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Glutamate-Energetics In Schizophrenia And Treatment Resistance
精神分裂症中的谷氨酸能量学和治疗抵抗
  • 批准号:
    MR/X021696/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Research Grant
The role of nigrostriatal and striatal cell subtype signaling in behavioral impairments related to schizophrenia
黑质纹状体和纹状体细胞亚型信号传导在精神分裂症相关行为障碍中的作用
  • 批准号:
    10751224
  • 财政年份:
    2024
  • 资助金额:
    $ 1.92万
  • 项目类别:
Molecular Genetic Studies of Schizophrenia: Understanding Treatment Resistance and Outcomes to Inform Precision Psychiatry.
精神分裂症的分子遗传学研究:了解治疗耐药性和结果,为精准精神病学提供信息。
  • 批准号:
    MR/Y004094/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Research Grant
Disentangling Genetic and Experiential Risk Factors for Cortical Abnormalities in a Mouse Model of Schizophrenia
解开精神分裂症小鼠模型皮质异常的遗传和经验危险因素
  • 批准号:
    MR/Y014693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Research Grant
Development of a new assessment and rehabilitation strategy with a focus on executive function in schizophrenia.
制定新的评估和康复策略,重点关注精神分裂症的执行功能。
  • 批准号:
    23K10440
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Brain Metabolome Atlas in Schizophrenia Mouse Models
精神分裂症小鼠模型的脑代谢组图谱
  • 批准号:
    23H02833
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Aripiprazole dose reduction in stable schizophrenia
稳定型精神分裂症阿立哌唑剂量减少
  • 批准号:
    23K06995
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of sphingomyelin synthesis to elucidate pathophysiology and disease concept in schizophrenia.
研究鞘磷脂合成以阐明精神分裂症的病理生理学和疾病概念。
  • 批准号:
    23K07012
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional characterization of schizophrenia rare variants using genetically engineered human iPSCs
使用基因工程人类 iPSC 进行精神分裂症罕见变异的功能表征
  • 批准号:
    10554598
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
Functional and behavioral dissection of higher order thalamocortical circuits in schizophrenia.
精神分裂症高阶丘脑皮质回路的功能和行为解剖。
  • 批准号:
    10633810
  • 财政年份:
    2023
  • 资助金额:
    $ 1.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了